Longitudinal analysis of soluble intercellular adhesion molecule 1 in retinal vasculitis patients

European Journal of Clinical Investigation

Volumn 26, Issue 8, 1996, Pages 686-691

  Palmer, H E ^a   Zaman, A G ^a   Ellis, B A ^a   Stanford, M R ^a   Graham, E M ^a   Wallace, G R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Relapse; Retinal vasculitis; Soluble intercellular adhesion molecule

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD RETINA BARRIER; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RELAPSE; RETINA VASCULITIS;

EID: 0029745303     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1996.tb02154.x     Document Type: Article

References (26)

1. Sanders MD, Duke-Elder Lecture. Retinal arteritis, retinal vasculitis and autoimmune retinal vasculitis. Eye 1987;1:441-65.
2. Forrester JV. Uveitis: pathogenesis. Lancet 1991;338:1498-504.
3. Forrester JV, McMenamin PG, Holthouse I, Lumsden L, Liversidge J. Localisation and characterisation of major histocompatibility complex class II positive cells in the posterior segment of the eye: implications for induction of autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 1994;35:64-77.
4. Konda BR, Pararajasegaram G, Wu G-S, Stanforth D, Rao NA. Role of retinal pigmented epithelium in the development of experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 1994;35:40-7.
5. Forrester JV, Liversidge J, Dua HS. Regulation of the local immune response by retinal cells. Curr Eye Res 1990;9:183-91.
6. Altmann DM, Hogg N, Trowsdale J, Wilkinson D. Co-transfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature 1989;338:512.
7. Martiney JA, Berman JW, Brosnan CF. Chronic inflammatory effects of interleukin-1 on the blood-retina barrier. J Neuroimmunol 1992;41:167-76.
8. Rosenbaum JT, Howes EL, Rubin RM, Samples JR. Ocular inflammatory effects of intravitreally injected tumour necrosis factor. Am J Ophthalmol 1988;133:47-53.
9. Liversidge J, Sewell HF, Forrester JV. Interaction between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology 1990;71:390-6.
10. Whitcup SM, Chan C-C, Li Q, Nussenblatt RB. Expression of cell adhesion molecules in posterior uveitis. Arch Ophthalmol 1992;110:662-6.
11. Makgoba MW, Sanders ME, Ginther-Luce GE et al. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1 dependent adhesion in T cell mediated cytotoxicity. Eur J Immunol 1988;18:637-40.
12. Thorp EM, Southern C, Bird IN, Matthews N. Tumour necrosis factor induction of ELAM-1 and ICAM-1 on human umbilical vein endothelial cells analysis of tumour necrosis factor receptor interactions. Cytokine 1992;4:313-19.
13. Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992;187:584.
14. Altomonte M, Colizzi F, Esposito G, Maio M. Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. New Engl J Med 1992;327:959.
15. Pizzolo G, Vinante F, Nadili G et al. ICAM-1 tissue over expression associated with increased serum levels of its soluble form in Hodgkin's disease. Br J Haematol 1993;84:161-2.
16. Becker JC, Termeer C, Schmidt RE, Brocker E-B. Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumour interaction. J Immunol 1993;151:7224-32.
17. Hauschild S, Schmitt WH, Kekow J, Szymkowiak C, Gross WL. Elevated serum levels of intercellular adhesion molecule-1 in Wegener's granulomatosis. Immun Infect 1992;20:84-90.
18. Seth R, Raymond FD, Makgoba MW. Circulating intercellular adhesion molecule-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991;338:83.
19. Zaman AG, Edelsten CE, Stanford MR et al. Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol 1994;95:60-5.
20. Nussenblatt RB et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985;92:467-71.
21. Cronstein BN, Kimmel SC, Levin RI, Martinuik F, Weissmann G. A mechanism for the anti-inflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci 1992;89:9991-5.
22. Shijubo N, Imai K, Aoki S et al. Circulating intercellular adhesion molecule-1 antigen in sera of patients with idiopathic pulmonary fibrosis. Clin Exp Immunol 1992;89:58-62.
23. Rieckmann P, Nunke K, Burchardt M et al. Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood cerebrospinal fluid barrier. J Neuroimmunol 1993;47:133-40.
24. Whitcup SM, DeBorge LR, Caspi RR, Harning R, Nussenblatt RB, Chan CC. Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis. Clin Immunol Immunopathol 1993;67:143-50.
25. Uchio E, Kijima M, Tanaka S-I. Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA 1. Invest Ophthalmol Vis Sci 1994;35:2626-31.
26. Ellis BA, Patel SY, Stanford MR et al. Tumour necrosis factor production by lipopolysaccharide-stimulated peripheral blood mononuclear cells from patients with retinal vasculitis. Regional Immunol 1995;6:27-30.